Lisa Kallenbach MD, Group Medical Director for US Medical Affairs, CAR-T, Johnson + Johnson Innovative Medicine | Speaker

Lisa is a Group Medical Director for US Medical Affairs, CAR-T at Johnson + Johnson Innovative Medicine. In this capacity, Lisa is a subject matter expert in multiple myeloma leads efforts to optimize care for patients with the disease who are treated with cilta-cel. Lisa is an experienced hematologist/oncologist and prior to joining Johnson +Johnson Innovative Medicine, she practiced at the Abramson Cancer Center at Penn Presbyterian Medical Center in Philadelphia. She also continues to work as a collaborator with Partners in Health in Rwanda helping to educate and train internists who provide cancer care at the Butaro Cancer Center of Excellence.  Lisa received her M.D. from the Warren Alpert Medical School of Brown University and completed a fellowship in hematology/oncology at Tufts Medical Center in Boston. She received an M.P.A. from New York University and a B.A. from the University of Pennsylvania.  She is a return Peace Corps Volunteer where she served in Guinea-Bissau, West Africa.